Co-pays are blocking access to million-dollar cures, researchers say
A peer-reviewed commentary argues traditional cost-sharing does more harm than good for curative cell and gene therapies
Search fresh public links, source activity, and ready-to-use post angles for Co-Pay Offset Programs.
Fresh curated links around Co-pay Offset Programs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A peer-reviewed commentary argues traditional cost-sharing does more harm than good for curative cell and gene therapies
The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs (rerun) Anonymous (not verified) Thu, 10/08/2026 - 07:08 pharmagather item url...
Keep Your Patient Program at the Forefront of Innovation at Patient Pathways: The Copay and Patient Services Congress November 17-20, 2026 | Sheraton Downtown Philadelphia Exclus...
WEDNESDAY, Aug. 26, 2026 — In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn’t afford the $750 monthly price tag. “I thought, ‘T...
Amazon and GoodRx are selling cash-pay prescription plans to insured workers. Those purchases usually sit outside the group plan, which matters for deductibles, claims data and 202...
Medicare launched a pilot program that could streamline the process to get GLP-1s, with some seniors paying just $50 a month. But many people with the most serious illnesses won't...
By Bryce Platt, PharmD Football season is officially back. Personally, my signal is hearing my uncle curse about bad calls from 1,000 miles away, but you may have already seen...
By Abdie Santiago & Jeffrey N. Wasserstein & Anne K. Walsh —
This week, we're rerunning some popular posts while we put the finishing touches on DCI’s 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Clic...
An analysis of commercial claims for 106 physician-administered outpatient drugs suggests $101 of additional plan spending per member per year stemming from site-of-treatment pay d...
The new Medicare GLP-1 Bridge program promises eligible beneficiaries access to popular weight loss drugs for as little as $50 a month. But for some, having the very medical condit...
A drug maker is paying $32 million to settle allegations it violated kickback laws by paying Medicare beneficiary co-pays to encourage the buying of its drug, Oxervate. Dompé U.S....
Three federal pricing changes are about to land on a single outpatient claim. The largest infusion and oncology programs will feel them first, and hardest. Most of the 340B debate...
Research from TOWARD Health and collaborating institutions reports LDL reductions nearly three times the conventional ezetimibe response and within the range reported in PCSK9 inhi...
President Trump sent $500 checks to some Affordable Care Act enrollees, while 20 million Medicare recipients will soon get $90 checks. Will they make a difference?
Plan sponsors pushback on cost drivers, PBM evaluation a crucial calling card for benefits brokers
Utilization growth is outrunning PBM discounts, and 2027 renewals are exposing the gap
Today's guest post comes from Bryce Aronson, Director of Business Development at AssistRx. Bryce covers three considerations taking effect in January 2027—the end of Medicare P...
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset...
Those with rare diseases and under prolonged treatment won't have to pay extra for prescription drugs that are similar to over-the-counter medicines.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.